EUVIMEDEUVIMED entdecken
Crossref

Evaluation of a Pharmacist-Led Intravenous Iron Therapy Transitions of Care Service in Heart Failure

Kazuhiko Kido iD, Bailey Colvin, Rachael Schauble, Christopher Bianco, Marco Caccamo iD, Kevin Felpel, George Sokos

Annals of Pharmacotherapy · 2025

DOI: 10.1177/10600280251389141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Pharmacotherapy, 2025. Verfasst von Kazuhiko Kido und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, West Virginia University School of Pharmacy, Morgantown, WV, USA. Hauptthemen laut MEDLINE: Heart Failure, Pharmacists, Ferric Compounds, Anemia, Iron-Deficiency. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The guidelines recommend intravenous (IV) iron for patients with heart failure (HF) with a reduced or mildly reduced ejection fraction. IV iron is often administered during hospitalization. However, care transitions from inpatient to outpatient settings for IV iron are suboptimal, and only about one-third of patients receive follow-up iron study measurements to assess the need for IV iron at outpatient settings after inpatient IV iron. Limited data is available to improve the current practice of IV iron during care transitions.

Objective

To evaluate the post-discharge performance of the pharmacist-led iron deficiency transitions of care initiative for patients with HF who received IV iron during hospitalization.

Methods

This retrospective cohort study included patients with HF who received ferric gluconate during hospitalization and was managed by the pharmacist-led iron deficiency transitions of care service (post-implementation group), compared to patients managed under the usual care during hospitalization (pre-implementation group). The primary outcome was the attainment of follow-up iron study and hemoglobin measurements within 6 months after the ferric gluconate induction course. The secondary outcomes included the provision of IV iron maintenance doses at outpatient settings for patients who had iron deficiency after the induction course.

Results

A total of 43 patients in the post-implementation group and 92 patients in the pre-implementation group were included in the analysis. The primary outcome was significantly higher in the post-implementation group (83.7 vs. 28.3%, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailurePharmacistsFerric CompoundsAnemia, Iron-DeficiencyHumansMaleRetrospective StudiesFemaleAgedMiddle AgedHospitalizationAdministration, IntravenousCohort StudiesPharmacy Service, HospitalAged, 80 and over

Stichwörter der Autor:innen

heart failurehospitalizationintravenous ironpharmacisttransitions of care

Substanzen

Ferric Compoundsferric gluconate

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, West Virginia University School of Pharmacy, Morgantown, WV, USA.
  • Department of Pharmacy, West Virginia University Medicine, Morgantown, WV, USA.
  • Department of Medicine, West Virginia University Medicine, Morgantown, WV, USA.

ORCID-Profile: Kazuhiko Kido, Marco Caccamo

Zitieren

APA

Kido, K., Colvin, B., Schauble, R., Bianco, C., Caccamo, M., Felpel, K., & Sokos, G. (2025). Evaluation of a Pharmacist-Led Intravenous Iron Therapy Transitions of Care Service in Heart Failure. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280251389141

Vancouver

Kido K, Colvin B, Schauble R, Bianco C, Caccamo M, Felpel K, et al. Evaluation of a Pharmacist-Led Intravenous Iron Therapy Transitions of Care Service in Heart Failure. Annals of Pharmacotherapy. 2025. doi:10.1177/10600280251389141

BibTeX
@article{Kido2025,
  author = {Kido, Kazuhiko and Colvin, Bailey and Schauble, Rachael and Bianco, Christopher and Caccamo, Marco and Felpel, Kevin and Sokos, George},
  title = {Evaluation of a Pharmacist-Led Intravenous Iron Therapy Transitions of Care Service in Heart Failure},
  journal = {Annals of Pharmacotherapy},
  year = {2025},
  doi = {10.1177/10600280251389141}
}
Kostenlos starten →